Track Prenetics Global Limited Warrant — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Prenetics Global Limited Warrant PRENW · Stock Open Prenetics Global Limited Warrant in new tab

0.0130 USD
EPS
-11.04
P/B
0.00
ROE
-40.77
Beta
0.24
Loading chart...
Key Metrics
Earnings dateSept. 11, 2026
EPS-11.04
Book Value9.76
Price to Book0.00
Debt/Equity0.38
Growth
Revenue Growth1.08%

DCF Valuation

Tweak assumptions to recompute fair value for Prenetics Global Limited Warrant (PRENW)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Prenetics Global Limited Warrant Logo Prenetics Global Limited Warrant Analysis (PRENW)

Hong Kong Health Care Official Website Stock

Is Prenetics Global Limited Warrant a good investment? Prenetics Global Limited Warrant (PRENW) is currently trading at 0.0130 USD.

Earnings Schedule: Prenetics Global Limited Warrant is expected to release its next earnings report on Sept. 11, 2026.

Investor FAQ

Does Prenetics Global Limited Warrant pay a dividend?

No, it does not currently pay a dividend.

What asset class is Prenetics Global Limited Warrant?

Prenetics Global Limited Warrant is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be Sept. 11, 2026. The company currently has a trailing EPS of -11.04.

Company Profile

Prenetics Global Limited operates as a consumer health sciences company in the United States and Hong Kong. The company focuses on advancing human health and longevity through science-backed products under the IM8 brand. It also operates a consumer genetic testing brand in CircleDNA leveraging sequencing technology to deliver personalized reports across various categories. The company was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.

Exchange Ticker
NMS (United States) PRENW
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion